Literature DB >> 24713117

Comparative responses to endocrine disrupting compounds in early life stages of Atlantic salmon, Salmo salar.

T A Duffy1, L R Iwanowicz2, S D McCormick3.   

Abstract

Atlantic salmon (Salmo salar) are endangered anadromous fish that may be exposed to feminizing endocrine disrupting compounds (EDCs) during early development, potentially altering physiological capacities, survival and fitness. To assess differential life stage sensitivity to common EDCs, we carried out short-term (4 day) exposures using three doses each of 17 α-ethinylestradiol (EE2), 17 β-estradiol (E2), and nonylphenol (NP) on four early life stages; embryos, yolk-sac larvae, feeding fry and 1 year old smolts. Differential response was compared using vitellogenin (Vtg, a precursor egg protein) gene transcription. Smolts were also examined for impacts on plasma Vtg, cortisol, thyroid hormones (T4/T3) and hepatosomatic index (HSI). Compound-related mortality was not observed in any life stage, but Vtg mRNA was elevated in a dose-dependent manner in yolk-sac larvae, fry and smolts but not in embryos. The estrogens EE2 and E2 were consistently stronger inducers of Vtg than NP. Embryos responded significantly to the highest concentration of EE2 only, while older life stages responded to the highest doses of all three compounds, as well as intermediate doses of EE2 and E2. Maximal transcription was greater for fry among the three earliest life stages, suggesting fry may be the most responsive life stage in early development. Smolt plasma Vtg was also significantly increased, and this response was observed at lower doses of each compound than was detected by gene transcription suggesting plasma Vtg is a more sensitive indicator at this life stage. HSI was increased at the highest doses of EE2 and E2, and plasma T3 was decreased at the highest dose of EE2. Our results indicate that all life stages are potentially sensitive to endocrine disruption by estrogenic compounds and that physiological responses were altered over a short window of exposure, indicating the potential for these compounds to impact fish in the wild.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atlantic salmon; Endocrine disruptor; Estradiol; Life stage; Nonylphenol; Vitellogenin

Mesh:

Substances:

Year:  2014        PMID: 24713117     DOI: 10.1016/j.aquatox.2014.03.015

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  4 in total

1.  Early-life exposure to 17β-estradiol and 4-nonylphenol impacts the growth hormone/insulin-like growth-factor system and estrogen receptors in Mozambique tilapia, Oreochromis mossambicus.

Authors:  Fritzie T Celino-Brady; Cody K Petro-Sakuma; Jason P Breves; Darren T Lerner; Andre P Seale
Journal:  Aquat Toxicol       Date:  2019-10-24       Impact factor: 4.964

2.  Low adaptive potential for tolerance to ethynylestradiol, but also low toxicity, in a grayling population (Thymallus thymallus).

Authors:  Lucas Marques da Cunha; Diane Maitre; Claus Wedekind
Journal:  BMC Evol Biol       Date:  2019-12-16       Impact factor: 3.260

Review 3.  Experimental Approaches for Characterizing the Endocrine-Disrupting Effects of Environmental Chemicals in Fish.

Authors:  Fritzie T Celino-Brady; Darren T Lerner; Andre P Seale
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

Review 4.  Suitability of Immobilized Systems for Microbiological Degradation of Endocrine Disrupting Compounds.

Authors:  Danuta Wojcieszyńska; Ariel Marchlewicz; Urszula Guzik
Journal:  Molecules       Date:  2020-09-29       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.